Stockreport

FDA Grants Orphan Drug Designation (ODD) to AlloVir’s Posoleucel, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy, for the Treatment of Virus-Associated Hemorrhagic Cysti...

AlloVir, Inc.  (ALVR) 
PDF ODD for posoleucel adds to RMAT designation by FDA and OMP and PRIME designations by EMAPhase 3 registrational study of posoleucel in virus-associated hemorrhagic cystit [Read more]